Analysis | Hit | start | end | length | Note | Hit coverage | Hit length | Hit pident | Hit pcons | eValue | Hit description |
blastp_kegg | bfu:BC1G_05099 | 1 | 99 | 99 | n/a | 30.18 | 328 | 100.00 | 0.00 | 8e-52 | similar to cyclin-dependent protein kinase |
ssl:SS1G_07226 | 1 | 99 | 99 | n/a | 30.18 | 328 | 96.97 | 3.03 | 1e-50 | negative regulator of the PHO system |
pno:SNOG_00798 | 1 | 98 | 98 | n/a | 22.95 | 427 | 93.88 | 4.08 | 1e-48 | hypothetical protein |
ncr:NCU07580 | 1 | 98 | 98 | n/a | 29.08 | 337 | 94.90 | 3.06 | 4e-48 | negative regulator of the PHO system |
fgr:FG05393.1 | 1 | 98 | 98 | n/a | 30.34 | 323 | 92.86 | 4.08 | 9e-48 | similar to AF145051_1 cyclin-dependent protein kinase |
ure:UREG_01891 | 1 | 97 | 97 | n/a | 29.31 | 331 | 92.78 | 5.15 | 3e-47 | negative regulator of the PHO system |
afm:AFUA_5G04130 | 1 | 98 | 98 | n/a | 25.19 | 389 | 92.86 | 4.08 | 5e-47 | cyclin-dependent protein kinase PhoA (EC:2.7.11.1) K08282 non-specific serine/threonine protein kinase [EC:2.7.11.1] |
afv:AFLA_006900 | 1 | 98 | 98 | n/a | 24.94 | 393 | 92.86 | 4.08 | 7e-47 | cyclin-dependent protein kinase PhoA |
ani:AN8261.2 | 1 | 98 | 98 | n/a | 26.78 | 366 | 92.86 | 4.08 | 8e-47 | similar to cyclin-dependent protein kinase PHOA(M1) |
nfi:NFIA_037990 | 1 | 98 | 98 | n/a | 29.61 | 331 | 92.86 | 4.08 | 1e-46 | cdk5 |
blastp_uniprot_sprot | sp|Q6C7U8|PHO85_YARLI | 8 | 98 | 91 | n/a | 30.95 | 294 | 89.01 | 7.69 | 5e-42 | Negative regulator of the PHO system OS Yarrowia lipolytica GN PHO85 PE 3 SV 1 |
sp|Q9HGY5|PHO85_CANAL | 8 | 98 | 91 | n/a | 27.91 | 326 | 86.81 | 5.49 | 3e-40 | Negative regulator of the PHO system OS Candida albicans GN PHO85 PE 3 SV 1 |
sp|Q6BRY2|PHO85_DEBHA | 8 | 97 | 90 | n/a | 27.27 | 330 | 86.67 | 6.67 | 2e-39 | Negative regulator of the PHO system OS Debaryomyces hansenii GN PHO85 PE 3 SV 2 |
sp|Q6FKD4|PHO85_CANGA | 8 | 98 | 91 | n/a | 30.13 | 302 | 80.22 | 8.79 | 6e-37 | Negative regulator of the PHO system OS Candida glabrata GN PHO85 PE 3 SV 1 |
sp|P17157|PHO85_YEAST | 8 | 98 | 91 | n/a | 29.84 | 305 | 81.32 | 6.59 | 1e-36 | Cyclin-dependent protein kinase PHO85 OS Saccharomyces cerevisiae GN PHO85 PE 1 SV 2 |
sp|Q92241|PHO85_KLULA | 7 | 97 | 91 | n/a | 29.93 | 304 | 79.12 | 7.69 | 6e-36 | Negative regulator of the PHO system OS Kluyveromyces lactis GN PHO85 PE 3 SV 2 |
sp|Q751E8|PHO85_ASHGO | 10 | 98 | 89 | n/a | 29.37 | 303 | 79.78 | 8.99 | 1e-35 | Negative regulator of the PHO system OS Ashbya gossypii GN PHO85 PE 3 SV 1 |
sp|O74456|PEF1_SCHPO | 9 | 98 | 90 | n/a | 31.25 | 288 | 76.67 | 15.56 | 2e-35 | Serine/threonine-protein kinase pef1 OS Schizosaccharomyces pombe GN pef1 PE 2 SV 2 |
sp|P34117|CDK5_DICDI | 10 | 101 | 92 | Gaps:1 | 31.85 | 292 | 69.89 | 12.90 | 5e-32 | Cell division protein kinase 5 homolog OS Dictyostelium discoideum GN cdk5 PE 2 SV 2 |
sp|P23437|CDK2_XENLA | 9 | 97 | 89 | Gaps:1 | 30.30 | 297 | 71.11 | 15.56 | 2e-31 | Cell division protein kinase 2 OS Xenopus laevis GN cdk2 PE 1 SV 3 |
blastp_pdb | 2pmi_C | 8 | 98 | 91 | n/a | 28.71 | 317 | 81.32 | 6.59 | 3e-37 | mol:protein length:317 Cyclin-dependent protein kinase PHO85 |
2pmi_A | 8 | 98 | 91 | n/a | 28.71 | 317 | 81.32 | 6.59 | 3e-37 | mol:protein length:317 Cyclin-dependent protein kinase PHO85 |
2pk9_C | 8 | 98 | 91 | n/a | 28.71 | 317 | 81.32 | 6.59 | 3e-37 | mol:protein length:317 Cyclin-dependent protein kinase PHO85 |
2pk9_A | 8 | 98 | 91 | n/a | 28.71 | 317 | 81.32 | 6.59 | 3e-37 | mol:protein length:317 Cyclin-dependent protein kinase PHO85 |
2iw8_C | 9 | 99 | 91 | Gaps:1 | 30.46 | 302 | 70.65 | 15.22 | 1e-32 | mol:protein length:302 CELL DIVISION PROTEIN KINASE 2 |
2iw8_A | 9 | 99 | 91 | Gaps:1 | 30.46 | 302 | 70.65 | 15.22 | 1e-32 | mol:protein length:302 CELL DIVISION PROTEIN KINASE 2 |
2ds1_A | 9 | 99 | 91 | Gaps:1 | 30.87 | 298 | 68.48 | 15.22 | 5e-31 | mol:protein length:298 Cell division protein kinase 2 |
1gij_A | 9 | 99 | 91 | Gaps:1 | 30.87 | 298 | 68.48 | 15.22 | 5e-31 | mol:protein length:298 CELL DIVISION PROTEIN KINASE 2 |
1gii_A | 9 | 99 | 91 | Gaps:1 | 30.87 | 298 | 68.48 | 15.22 | 5e-31 | mol:protein length:298 CELL DIVISION PROTEIN KINASE 2 |
3lfs_A | 9 | 99 | 91 | Gaps:1 | 30.87 | 298 | 68.48 | 15.22 | 5e-31 | mol:protein length:298 Cell division protein kinase 2 |
rpsblast_cdd | gnl|CDD|143341 | 9 | 98 | 90 | n/a | 31.69 | 284 | 91.11 | 6.67 | 4e-51 | cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs) Pho85 subfamily catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs protein tyrosine kinases RIO kinases aminoglycoside phosphotransferase choline kinase and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together they are involved in the control of cell-cycle progression transcription and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression cell polarity phosphate and glycogen metabolism gene expression and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5 which plays a role in central nervous system development. |
gnl|CDD|173733 | 10 | 98 | 89 | Gaps:1 | 31.91 | 282 | 68.89 | 15.56 | 1e-40 | cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs) Cyclin-Dependent protein Kinase (CDK)-like subfamily catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs protein tyrosine kinases RIO kinases aminoglycoside phosphotransferase choline kinase and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together they are involved in the control of cell-cycle progression transcription and neuronal function. CDKs are partly regulated by their subcellular localization which defines substrate phosphorylation and the resulting specific function. CDK1 CDK2 CDK4 and CDK6 have well-defined functions in the cell cycle such as the regulation of the early G1 phase by CDK4 or CDK6 the G1/S phase transition by CDK2 or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes showing that some CDKs can compensate for each other. For example CDK4 can compensate for the loss of CDK6 however double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. |
gnl|CDD|173738 | 10 | 98 | 89 | Gaps:1 | 31.80 | 283 | 66.67 | 17.78 | 1e-39 | cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs) Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs protein tyrosine kinases RIO kinases aminoglycoside phosphotransferase choline kinase and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together they are involved in the control of cell-cycle progression transcription and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes plants and yeasts as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase and is regulated by cyclins A B and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. |
gnl|CDD|143349 | 8 | 97 | 90 | n/a | 30.93 | 291 | 65.56 | 21.11 | 1e-38 | cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs) PCTAIRE-like subfamily catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs protein tyrosine kinases RIO kinases aminoglycoside phosphotransferase choline kinase and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs) which belong to a large family of STKs that are regulated by their cognate cyclins. Together CDKs and cyclins are involved in the control of cell-cycle progression transcription and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues suggesting that they may be involved in regulating post-mitotic cellular events. |
gnl|CDD|173751 | 9 | 99 | 91 | Gaps:1 | 32.39 | 284 | 68.48 | 15.22 | 1e-38 | cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs) Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs protein tyrosine kinases RIO kinases aminoglycoside phosphotransferase choline kinase and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together they are involved in the control of cell-cycle progression transcription and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2 together with CDK4 also regulates embryonic cell proliferation. Despite these important roles mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2) which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. |
gnl|CDD|143344 | 9 | 101 | 93 | Gaps:1 | 33.10 | 284 | 60.64 | 21.28 | 3e-37 | cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs) Cyclin-Dependent protein Kinase 5 (CDK5) subfamily catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs protein tyrosine kinases RIO kinases aminoglycoside phosphotransferase choline kinase and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together they are involved in the control of cell-cycle progression transcription and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease amyotrophic lateral sclerosis Parkinson's disease Huntington's disease and acute neuronal injury. |
gnl|CDD|173752 | 10 | 98 | 89 | Gaps:1 | 31.58 | 285 | 60.00 | 23.33 | 8e-35 | cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs) Cyclin-Dependent protein Kinase 1 (CDK1) subfamily catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs protein tyrosine kinases RIO kinases aminoglycoside phosphotransferase choline kinase and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together they are involved in the control of cell-cycle progression transcription and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase and is regulated by cyclins A B and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation nuclear membrane degradation mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. |
gnl|CDD|143376 | 9 | 97 | 89 | n/a | 30.90 | 288 | 67.42 | 16.85 | 5e-32 | cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs) PCTAIRE-3 subfamily catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs protein tyrosine kinases RIO kinases aminoglycoside phosphotransferase choline kinase and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs) which belong to a large family of STKs that are regulated by their cognate cyclins. Together CDKs and cyclins are involved in the control of cell-cycle progression transcription and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain kidney and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses phosphorylated Tau aggregates and forms PHFs which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells PCTAIRE-3 induces cell cycle arrest and cell death. |
gnl|CDD|143377 | 9 | 97 | 89 | n/a | 28.80 | 309 | 68.54 | 17.98 | 6e-32 | cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs) PCTAIRE-2 subfamily catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs protein tyrosine kinases RIO kinases aminoglycoside phosphotransferase choline kinase and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs) which belong to a large family of STKs that are regulated by their cognate cyclins. Together CDKs and cyclins are involved in the control of cell-cycle progression transcription and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. |
gnl|CDD|143378 | 9 | 97 | 89 | n/a | 29.57 | 301 | 67.42 | 19.10 | 2e-31 | cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs) PCTAIRE-1 subfamily catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs protein tyrosine kinases RIO kinases aminoglycoside phosphotransferase choline kinase and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs) which belong to a large family of STKs that are regulated by their cognate cyclins. Together CDKs and cyclins are involved in the control of cell-cycle progression transcription and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2) a physiological partner of PCTAIRE-2 with p11 a small dimeric protein with similarity to S100 and with 14-3-3 proteins mediators of phosphorylation-dependent interactions in many different proteins. |
rpsblast_kog | gnl|CDD|35881 | 10 | 101 | 92 | Gaps:1 | 31.85 | 292 | 62.37 | 18.28 | 1e-33 | KOG0662 KOG0662 KOG0662 Cyclin-dependent kinase CDK5 [Intracellular trafficking secretion and vesicular transport Signal transduction mechanisms]. |
gnl|CDD|35814 | 1 | 98 | 98 | Gaps:8 | 32.82 | 323 | 56.60 | 15.09 | 5e-30 | KOG0594 KOG0594 KOG0594 Protein kinase PCTAIRE and related kinases [General function prediction only]. |
gnl|CDD|35820 | 8 | 92 | 85 | Gaps:3 | 15.71 | 560 | 47.73 | 26.14 | 4e-21 | KOG0600 KOG0600 KOG0600 Cdc2-related protein kinase [Cell cycle control cell division chromosome partitioning]. |
gnl|CDD|35878 | 7 | 92 | 86 | Gaps:1 | 27.36 | 318 | 49.43 | 21.84 | 5e-21 | KOG0659 KOG0659 KOG0659 Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK kinase subunit CDK7 [Cell cycle control cell division chromosome partitioning Transcription Replication recombination and repair]. |
gnl|CDD|35882 | 5 | 98 | 94 | Gaps:3 | 23.15 | 419 | 35.05 | 32.99 | 1e-18 | KOG0663 KOG0663 KOG0663 Protein kinase PITSLRE and related kinases [General function prediction only]. |
gnl|CDD|35813 | 10 | 92 | 83 | Gaps:3 | 21.21 | 396 | 44.05 | 26.19 | 4e-17 | KOG0593 KOG0593 KOG0593 Predicted protein kinase KKIAMRE [General function prediction only]. |
gnl|CDD|35815 | 10 | 96 | 87 | Gaps:2 | 20.75 | 429 | 34.83 | 24.72 | 1e-14 | KOG0595 KOG0595 KOG0595 Serine/threonine-protein kinase involved in autophagy [Posttranslational modification protein turnover chaperones Intracellular trafficking secretion and vesicular transport Signal transduction mechanisms]. |
gnl|CDD|35801 | 2 | 90 | 89 | Gaps:1 | 24.73 | 364 | 27.78 | 24.44 | 2e-13 | KOG0581 KOG0581 KOG0581 Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]. |
gnl|CDD|35880 | 10 | 96 | 87 | Gaps:2 | 16.54 | 538 | 35.96 | 22.47 | 2e-12 | KOG0661 KOG0661 KOG0661 MAPK related serine/threonine protein kinase [Signal transduction mechanisms]. |
gnl|CDD|35879 | 7 | 96 | 90 | Gaps:6 | 26.74 | 359 | 33.33 | 21.88 | 1e-11 | KOG0660 KOG0660 KOG0660 Mitogen-activated protein kinase [Signal transduction mechanisms]. |